The page below is a sample from the LabCE course OSHA Bloodborne Pathogens for Healthcare Personnel. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about OSHA Bloodborne Pathogens for Healthcare Personnel (online CE course) »
How to Subscribe

Recent Information Regarding HCV Infection and Treatment

According to the CDC, persons born between 1945-1965 account for three-fourths of the cases of HCV infection. This group is also at greatest risk for hepatocellular carcinoma and other HCV-related liver diseases. The CDC recommends a one-time HCV testing for all persons born between 1945-1965.
Although there is still no vaccine for HCV, there are now several treatment options available. In October 2014, the FDA approved a once-daily tablet treatment for chronic HCV genotype 1, the most common form of HCV in the United States. This treatment has proven cure rates of 94-99%. An infected individual is considered cured, if the virus is not detected in the blood 12 weeks after completion of treatment.